Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...
Fractyl Health announced a first-in-human trial for RJVA-001, targeting T2D and obesity, pending regulatory approval by 2026. Fractyl Health, Inc. has announced the submission of the first module of ...
The search for gene therapies to treat rheumatoid arthritis (RA) has moved in fits and starts over the past two decades, with trials starting and stopping, and their focus shifting to osteoarthritis ...
Researchers used evolutionary genetics and CRISPR gene editing tech to develop an innovative treatment for gout. The approach ...
Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to ...
Clinical trials of a groundbreaking new gene therapy for Huntington's disease have shown that it slows progression of the ...
Scientists from Tel Aviv University and Boston Children's Hospital use a optimized virus to deliver a corrected gene into the ...
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...
The race to advance gene editing tech continues, spurred on by starry-eyed Silicon Valley investors, entrepreneurs and even ...